A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts.
A possible third COVID vaccine could be on the way in the U.S. It is sorely needed to ramp up vaccinations. Nearly 34 million Americans have had at least one COVID shot, but that means more than 8 in 10 have not. Late Thursday, Johnson & Johnson is filing with the FDA for ...
US expert panel endorses Johnson & Johnson's one-dose COVID-19 vaccine; FDA will make final decision soon. By Associated Press | Feb. 26, 2021, at 5:04 p.m. Save More US Expert Panel Endorses Johnson & Johnson's One-Dose COVID-19 Vaccine; FDA Will Mak...
In phase 3, J&J's vaccine was 66% effective overall at preventing moderate-to-severe COVID-19Johnson & Johnson (J&J) has submitted an application to the World Health Organization (WHO) seeking an emergency use listing (EUL) for its one-dose COVID-19 vaccine. The WHO subm...
The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is bei...
Canada’s first shipment of Johnson & Johnson’s single-dose COVID-19 vaccine is expected to arrive in the coming days, but provinces are still waiting for guidance on how best to use them. Procurement Minister Anita Anand said last week that Canada would receive 300,000 doses by the...
A possible third coronavirus vaccine could be on the way in the U.S. as the nation ramps up immunizations. Nearly 34 million Americans have had at least one COVID shot so far. Meg Oliver reports.Feb 5, 2021 Facebook Email Live Now ...
Johnson & Johnson has advanced its one-shot COVID-19 vaccine into phase 3 testing. The National Institute of Allergy and Infectious Diseases describes this as the fourth candidate to reach this stage.
Recently, a single dose of the COVID-19 vaccine has been administered in many districts of Shanghai. According to the Shanghai Center for Disease Control and Prevention, different types of vaccines require different doses due to different research and development technology routes and production pro...
Adults infected with covid-19 three weeks after receiving one dose of the Pfizer-BioNTech or Oxford-AstraZeneca vaccine were 38-49% less likely to pass the virus on to their household contacts than people who were unvaccinated, a preprint released by Public Health England has shown.1 The ...